ESC 365 - This programme is supported by Novo Nordisk in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor

EAPC Premium Access

This programme is supported by Novo Nordisk in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor

Session: Cardiovascular risk in type 2 diabetes mellitus: how to assess and, how to manage?

Topic: Diabetes and the Heart

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

6 more presentations in this session

Assessing CV risk in patients with type 2 diabetes: SCORE-2 diabetes

Speaker: Professor E. Di Angelantonio (Cambridge, GB)

Assessing CV risk in patients with type 2 diabetes: lessons learned from imaging

Speaker: Professor J. Pitha (Prague, CZ)

Diabetes, microangiopathy and macroangiopathy: how are they related?

Speaker: Professor C. Stehouwer (Maastricht, NL)

Exercise in patients with T2D: how to manage

Speaker: Professor D. Hansen (Hasselt, BE)

Discussion – Cardiovascular risk in type 2 diabetes mellitus: how to assess and, how to manage?

Access the full session

Cardiovascular risk in type 2 diabetes mellitus: how to assess and, how to manage?

Speakers: Professor E. Di Angelantonio, Professor J. Pitha, Professor C. Stehouwer, Professor D. Hansen

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources